Ochi, Hiroshi
997  Ergebnisse:
Personensuche X
?
1

Effectiveness and safety of primary prophylaxis of G-CSF du..:

Kimura, Shoji ; Shigeta, Keisuke ; Tamura, Shingo...
International Journal of Clinical Oncology.  29 (2024)  5 - p. 559-563 , 2024
 
?
2

Therapeutic use of granulocyte colony-stimulating factor (G..:

Tsuchihashi, Kenji ; Ito, Mamoru ; Okumura, Yuta...
International Journal of Clinical Oncology.  29 (2024)  6 - p. 700-705 , 2024
 
?
3

Serum MYCN as a predictive biomarker of prognosis and thera..:

Qin, Xian‐Yang ; Shirakami, Yohei ; Honda, Masao...
International Journal of Cancer.  155 (2024)  3 - p. 582-594 , 2024
 
?
5

Effectiveness and safety of primary prophylaxis of granuloc..:

Uchino, Keita ; Tamura, Shingo ; Kimura, Shoji...
International Journal of Clinical Oncology.  29 (2024)  5 - p. 545-550 , 2024
 
?
6

Primary prophylaxis with G-CSF for patients with non-round ..:

Hirose, Takeshi ; Ito, Mamoru ; Tsuchihashi, Kenji...
International Journal of Clinical Oncology.  29 (2024)  8 - p. 1067-1073 , 2024
 
?
7

Optimal timing of prophylactic pegylated G-CSF after chemot..:

Ozaki, Yukinori ; Yokoe, Takamichi ; Yoshinami, Tetsuhiro...
International Journal of Clinical Oncology.  29 (2024)  5 - p. 551-558 , 2024
 
?
8

Effectiveness and safety of primary prophylaxis with G-CSF ..:

Maeda, Tomoya ; Najima, Yuho ; Kamiyama, Yutaro...
International Journal of Clinical Oncology.  29 (2024)  5 - p. 535-544 , 2024
 
?
9

Effectiveness and safety of primary prophylaxis with G-CSF ..:

Hirose, Takeshi ; Ito, Mamoru ; Tsuchihashi, Kenji...
International Journal of Clinical Oncology.  29 (2024)  8 - p. 1081-1087 , 2024
 
?
 
?
12

Effectiveness and safety of granulocyte colony-stimulating ..:

Najima, Yuho ; Maeda, Tomoya ; Kamiyama, Yutaro...
International Journal of Clinical Oncology.  29 (2024)  7 - p. 899-910 , 2024
 
?
13

Screening of novel DPP-IV inhibitory peptides derived from ..:

Arai, Sayuri ; Kurimoto, Masaki ; Nakada, Hajime...
Journal of Bioscience and Bioengineering.  137 (2024)  2 - p. 94-100 , 2024
 
1-15